Evidence map›Paper›PMID 34073202›Full record

ArticleMaterials (Basel, Switzerland)2021

Chitosan-Coated Halloysite Nanotubes As Vehicle for Controlled Drug Delivery to MCF-7 Cancer Cells In Vitro.

Emmanuel Nyankson, Shadrack O Aboagye, Johnson Kwame Efavi, Benjamin Agyei-Tuffour, Lily Paemka, Bernard O Asimeng, Srinivasan Balapangu, Patrick K Arthur, Elvis K Tiburu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Curcumin loaded Ag-TiORSC advances · 2022
    Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Emmanuel NyanksonDepartment of Materials Science and Engineering, University of Ghana, P.O. Box LG77 Legon, Ghana.ORCID 0000-0001-7041-3466
Shadrack O AboagyeDepartment of Materials Science and Engineering, University of Ghana, P.O. Box LG77 Legon, Ghana.
Johnson Kwame EfaviDepartment of Materials Science and Engineering, University of Ghana, P.O. Box LG77 Legon, Ghana.
Benjamin Agyei-TuffourDepartment of Materials Science and Engineering, University of Ghana, P.O. Box LG77 Legon, Ghana.ORCID 0000-0001-9629-8240
Lily PaemkaDepartment Biochemistry, Cell and Molecular Biology, University of Ghana, P.O. Box LG54 Legon, Ghana.
Bernard O AsimengDepartment of Biomedical Engineering, University of Ghana, P.O. Box LG77 Legon, Ghana.
Srinivasan BalapanguWest Africa Center for Cell Biology of Infectious Pathogens, University of Ghana, Legon, Ghana.
Patrick K ArthurDepartment Biochemistry, Cell and Molecular Biology, University of Ghana, P.O. Box LG54 Legon, Ghana.ORCID 0000-0002-5974-3955
Elvis K TiburuWest Africa Center for Cell Biology of Infectious Pathogens, University of Ghana, Legon, Ghana.ORCID 0000-0002-1259-5254

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the work is to improve the release properties of curcumin onto human breast cancer cell lines using coated halloysite nanotubes (HNTs) with chitosan as a polycation. A loading efficiency of 70.2% (

Indexed as

breast cancer cell linechitosancurcuminhalloysite nanotubessustained and targeted release

Identifiers

PMID34073202
PMCPMC8198553

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.